28 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Arcturus Therapeutics Holdings Inc. ARCT shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also said ARCT-021 will begin multinational placebo-controlled Phase 3 efficacy study funded & sponsored by a global entity.
• Dynatronics Corporation DYNT rose 34.6% to $1.75 in pre-market trading after the company reported strong preliminary sales for the fourth quarter.
• BioHiTech Global, Inc. BHTG rose 21.6% to $1.72 in pre-market trading after the company reported strong Q2 sales.
• Myomo, Inc. MYO rose 19.5% to $9.38 in pre-market trading after reporting upbeat Q2 results.
• Fisker Inc. FSR rose 12.4% to $16.89 in pre-market trading. Morgan Stanley resumed covered on the stock with a Buy rating and a $40 price target and set its bull-case scenario at $90.
• Lufax Holding Ltd LU rose 11.6% to $8.35 in pre-market trading after reporting upbeat quarterly earnings.
• 3D Systems Corporation DDD shares rose 11.2% to $31.52 in pre-market trading after the company reported better-than-expected results for its second quarter on Monday.
• AMC Entertainment Holdings, Inc. AMC rose 10% to $37.18 in pre-market trading after the company reported stronger-than-expected results for its second quarter. The company said it currently has liquidity availability of more than $2 billion. AMC also announced plans to begin accepting apex cryptocurrency Bitcoin as payment for move tickets and concessions by the end of this year.
• Astra Space, Inc. ASTR shares rose 9.8% to $12.30 in pre-market trading after the company was awarded Orbital Services Program (OSP)-4 contract by the Space Force.
• The9 Limited NCTY shares rose 9.5% to $18.46 in pre-market trading after gaining around 20% on Monday. The9 Limited and KazDigital, a Kazakhstan cryptomining company, recently signed a term sheet on establishment of joint venture.
• Oramed Pharmaceuticals Inc. ORMP shares rose 8.7% to $22.92 in pre-market trading after climbing over 15% on Monday. The company’s partner Premas Biotech recently signed a Licensing deal for virus-like particle injectable vaccine technology for Covid-19, with Oravax for commercialization in India.
• Purple Innovation, Inc. PRPL rose 8.3% to $26.81 in pre-market trading after the company swung to a profit in the second quarter. The company also issued FY21 sales guidance.
• SOC Telemed, Inc. TLMD rose 7.5% to $4.90 in pre-market trading after gaining 7% on Monday.
• ZK International Group Co., Ltd. ZKIN shares rose 7.4% to $3.94 in pre-market trading after jumping about 15% on Monday.
• Ebang International Holdings Inc. EBON rose 6.1% to $3.00 in pre-market trading after gaining around 10% on Monday.
• Calliditas Therapeutics AB CALT rose 5.6% to $31.15 in pre-market trading. The FDA granted Fast Track Designation to Calliditas Therapeutics lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).
• Kansas City Southern KSU rose 4.3% to $281.00 in pre-market trading following a report suggesting Canadian Pacific plans a new higher bid for the company, near $300 per share.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Metromile, Inc. MILE shares fell 18.7% to $5.67 in pre-market trading after the company reported a wider-than-expected Q2 loss.
• SmileDirectClub, Inc. SDC fell 15.8% to $5.64 in pre-market trading after the company reported worse-than-expected Q2 results and issued weak FY21 sales guidance.
• Fulgent Genetics, Inc. FLGT shares fell 15.3% to $93.01 in pre-market trading after the company reported worse-than-expected Q2 results. Fulgent Genetics and Helio Health also reported a partnership to commercialize early cancer detection tests.
• Reata Pharmaceuticals, Inc. RETA fell 14.8% to $104.00 in pre-market trading after the company reported Q2 earnings and provided an update on clinical development programs.
• Washington Prime Group Inc. WPG fell 14.3% to $1.44 in pre-market trading after the company reported Q2 earnings results.
• Waitr Holdings Inc. WTRH fell 9.4% to $1.44 in pre-market trading after the company reported downbeat Q2 results. The company also reported the purchase of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC.
• Senseonics Holdings, Inc. SENS shares fell 8.6% to $2.97 in pre-market trading after the company reported Q2 earnings results and issued FY21 guidance.
• Vuzix Corporation VUZI fell 8.5% to $12.56 in pre-market trading after the company reported worse-than-expected Q2 results.
• Aptinyx Inc. APTX fell 7.8% to $2.38 in pre-market trading ahead of Q2 results.
• Liminal BioSciences Inc. LMNL fell 6% to $3.43 in pre-market trading. Liminal BioSciences jumped around 28% on Monday as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million.
• BioCryst Pharmaceuticals, Inc. BCRX shares fell 5.8% to $16.62 in pre-market trading after the company announced it commenced a public offering of $200 million of common stock and pre-funded warrants.